Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release

Details for Australian Patent Application No. 2008214338 (hide)

Owner Redpoint Bio Corporation

Inventors Morgan, Gillian; Lee, S. Paul; Salemme, F. Raymond; Cerne, Rok; Buber, M.N. Tulu; Bryant, Robert; Zhou, Peihong

Agent Peter Maxwell & Associates

Pub. Number AU-A-2008214338

PCT Pub. Number WO2008/097504

Priority 60/887,996 02.02.07 US; 61/016,394 21.12.07 US

Filing date 4 February 2008

Wipo publication date 14 August 2008

International Classifications

A61K 31/655 (2006.01) - Azo (NN), diazo (N), azoxy (NON or N(O)N), azido (N) or diazoamino (NNN) compounds

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/097504 Priority application(s): WO2008/097504

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008214343-Item level inventory with a radio frequency identification (RFID) system

2008214337-Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation